Memphasys Appoints New Chair Amid Key Developments
Memphasys Ltd (AU:MEM) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Memphasys Limited has appointed Lindley Edwards as the new Non-Executive Chairperson, succeeding Robert Cooke, as the company nears the completion of its clinical trial for the Felix™ System. Edwards brings over 30 years of experience in financial services and corporate governance, aiming to steer Memphasys towards global commercialisation of its sperm separation technology and RoXsta™ System. These advancements are set to strengthen Memphasys’ position in the fertility and biotechnology markets.
For further insights into AU:MEM stock, check out TipRanks’ Stock Analysis page.
Trending Articles
TipRanks is the most comprehensive data set of sell side analysts and hedge fund managers. TipRanks' multi-award winning platform ranks financial experts based on measured performance and the accuracy of their predictions so investors know who to trust when making investment decisions.